GOLIMUMAB

65571 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking GOLIMUMAB:

# Side effect Count
0 DRUG INEFFECTIVE 18514
1 RHEUMATOID ARTHRITIS 11101
2 PAIN 10600
3 FATIGUE 8723
4 ARTHRALGIA 7342
5 JOINT SWELLING 7266
6 DRUG INTOLERANCE 7177
7 ALOPECIA 7067
8 OFF LABEL USE 7047
9 RASH 6881
See all common reactions for GOLIMUMAB

GOLIMUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 952 0.8366
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3341 0.8359
2 RHEUMATIC FEVER 1169 0.7626
3 PEMPHIGUS 5839 0.7164
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 161 0.6940
5 LUPUS VULGARIS 139 0.6847
6 RHEUMATOID FACTOR POSITIVE 2274 0.6370
7 DUODENAL ULCER PERFORATION 2338 0.6353
8 RED BLOOD CELL SEDIMENTATION RATE 157 0.6062
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 313 0.6008
See all enriched reactions for GOLIMUMAB